Phase I/II clinical trials using gene-modified adult hematopoietic stem cells for HIV: Lessons learnt

Stem Cells International

Volumn , Issue , 2011, Pages

  Mitsuyasu, Ronald T ^a   Zack, Jerome A ^a   MacPherson, Janet L ^b   Symonds, Geoff P ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Genetics University of California Los Angeles ^*  (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; CCR5 RIBOZYME; GENE THERAPY AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; LENTIVIRUS VECTOR; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; OZ1 RETROVIRUS VECTOR; PLACEBO; RETROVIRUS VECTOR; REV PROTEIN; REV RESPONSIVE ELEMENT DECOY; REV RIBOZYME; RIBOZYME; STEM CELL FACTOR; TAR DECOY; TAT RIBOZYME; UNCLASSIFIED DRUG; VPR RIBOZYME;

ABSENCE OF SIDE EFFECTS; ADULT STEM CELL; APHERESIS; CD34 SELECTION; CD4 LYMPHOCYTE COUNT; CD4+ HEMATOPOIETIC STEM CELL; DNA MODIFICATION; ENGRAFTMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLONEY LEUKEMIA ONCOVIRUS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; STEM CELL GENE THERAPY; STEM CELL MOBILIZATION; UNSPECIFIED SIDE EFFECT; VIRUS LOAD; VIRUS REPLICATION;

EID: 80052777732     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.4061/2011/393698     Document Type: Review

References (47)

1. Taylor B. S., Sobieszczyk M. E., McCutchan F. E., Hammer S. M., The challenge of HIV-1 subtype diversity The New England Journal of Medicine 2008 358 15 1590 1602
2. Watkins D. I., Burton D. R., Kallas E. G., Moore J. P., Koff W. C., Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans Nature Medicine 2008 14 6 617 621 (Pubitemid 351809543)
3. Baltimore D., Intracellular immunization Nature 1988 335 6189 395 396
4. Amado R. G., Mitsuyasu R. T., Rosenblatt J. D., Ngok F. K., Bakker A., Cole S., Chorn N., Lin L. S., Bristol G., Boyd M. P., Macpherson J. L., Fanning G. C., Todd A. V., Ely J. A., Zack J. A., Symonds G. P., Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients Human Gene Therapy 2004 15 3 251 262 (Pubitemid 38365914)
5. Dong S. A., Donahue R. E., Kamata M., Poon B., Metzger M., Mao SI. H., Bonifacino A., Krouse A. E., Darlix J. L., Baltimore D., Qin F. X. F., Chen I. S. Y., Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates Proceedings of the National Academy of Sciences of the United States of America 2007 104 32 13110 13115 (Pubitemid 351737601)
6. Anderson J., Li M. J., Palmer B., Remling L., Li S., Yam P., Yee J. K., Rossi J., Zaia J., Akkina R., Safety and efficacy of a lentiviral vector containing cthree anti-HIV genesCCR5 ribozyme, tat-rev siRNA, and TAR decoyin SCID-hu mouse-derived t cells Molecular Therapy 2007 15 6 1182 1188 (Pubitemid 46813622)
7. Bahner I., Zhou C., Yu X. J., Hao Q. L., Guatelli J. C., Kohn D. B., Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes Journal of Virology 1993 67 6 3199 3207 (Pubitemid 23143690)
8. Cagnon L., Rossi J., Retroviral delivery and anti-HIV testing of hammerhead ribozymes Methods in Molecular Biology 1997 74 451 457
9. Dropulic B., Elkins D. A., Rossi J. J., Sarver N., Ribozymes: use as Anti-HIV therapeutic molecules Antisense Research and Development 1993 3 1 87 94 (Pubitemid 23152129)
10. Fanning G., Amado R., Gymonds G., Gene therapy for HIV/AIDS: the potential for a new therapeutic regimen Journal of Gene Medicine 2003 5 8 645 653 (Pubitemid 40309703)
11. Kohn D. B., Gene therapy using hematopoietic stem cells Current Opinion in Molecular Therapeutics 1999 1 4 437 442 (Pubitemid 29420038)
12. Kohn D. B., Bauer G., Rice C. R., Rothschild J. C., Carbonaro D. A., Valdez P., Hao Q. L., Zhou C., Bahner I., Kearns K., Brody K., Fox S., Haden E., Wilson K., Salata C., Dolan C., Wetter C., Aguilar-Cordova E., Church J., A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34 cells from the bone marrow of human immunodeficiency virus-1-infected children Blood 1999 94 1 368 371 (Pubitemid 29300172)
13. Li M., Li H., Rossi J. J., RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy Annals of the New York Academy of Sciences 2006 1082 172 179 (Pubitemid 44955461)
14. Lo A. S., Zhu Q., Marasco W. A., Intracellular antibodies (intrabodies) and their therapeutic potential Handbook of experimental pharmacology 2008 181 343 373
15. Marasco W. A., Lavecchio J., Winkler A., Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1- infection and AIDS Journal of Immunological Methods 1999 231 1-2 223 238 (Pubitemid 30394736)
16. Mautino M. R., Morgan R. A., Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNA Human Gene Therapy 2000 11 14 2025 2037
17. Morgan R. A., Walker R., Carter C. S., Natarajan V., Tavel J. A., Bechtel C., Herpin B., Muul L., Zheng Z., Jagannatha S., Bunnell B. A., Fellowes V., Metcalf J. A., Stevens R., Baseler M., Leitman S. F., Read E. J., Blaese R. M., Lane H. C., Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals Human Gene Therapy 2005 16 9 1065 1074 (Pubitemid 41324566)
18. Morris K. V., Rossi J. J., Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection Human Gene Therapy 2006 17 5 479 486 (Pubitemid 43794487)
19. Rossi J. J., The application of ribozymes to HIV infection Current Opinion in Molecular Therapeutics 1999 1 3 316 322 (Pubitemid 29309179)
20. Strayer D. S., Akkina R., Bunnell B. A., Dropulic B., Planelles V., Pomerantz R. J., Rossi J. J., Zaia J. A., Current status of gene therapy strategies to treat HIV/AIDS Molecular Therapy 2005 11 6 823 842 (Pubitemid 40724101)
21. Taylor J. A., Vojtech L., Bahner I., Kohn D. B., Laer D. V., Russell D. W., Richard R. E., Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication Molecular Therapy 2008 16 1 46 51
22. von Laer D., Hasselmann S., Hasselmann K., Gene therapy for HIV infection: what does it need to make it work? Journal of Gene Medicine 2006 8 6 658 667
23. Zahn R. C., Hermann F. G., Kim E. Y., Rett M. D., Wolinsky S. M., Johnson R. P., Villinger F., von Laer D., Schmitz J. E., Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides Gene Therapy 2008 15 17 1210 1222
24. Sarver N., Cantin E. M., Chang P. S., Zaia J. A., Ladne P. A., Stephens D. A., Rossi J. J., Ribozymes as potential anti-HIV-1 therapeutic agents Science 1990 247 4947 1222 1225
25. Schambach A., Schiedlmeier B., Khlcke K., Verstegen M., Margison G. P., Li Z., Kamino K., Bohne J., Alexandrov A., Hermann F. G., von Laer D., Baum C., Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus Gene Therapy 2006 13 13 1037 1047 (Pubitemid 43905856)
26. Rossi J. J., June C. H., Kohn D. B., Genetic therapies against HIV Nature Biotechnology 2007 25 12 1444 1454 (Pubitemid 350233141)
27. Macpherson J. L., Ely J. A., Sun L. Q., Symonds G. P., Ribozymes in gene therapy of HIV-1 Frontiers in Biosciencey 1999 4 D497 D505
28. Levine B. L., Humeau L. M., Boyer J., MacGregor R. R., Rebello T., Lu X., Binder G. K., Slepushkin V., Lemiale F., Mascola J. R., Bushman F. D., Dropulic B., June C. H., Gene transfer in humans using a conditionally replicating lentiviral vector Proceedings of the National Academy of Sciences of the United States of America 2006 103 46 17372 17377 (Pubitemid 44788976)
29. Macpherson J. L., Boyd M. P., Arndt A. J., Todd A. V., Fanning G. C., Ely J. A., Elliott F., Knop A., Raponi M., Murray J., Gerlach W., Sun L. Q., Penny R., Symonds G. P., Carr A., Cooper D. A., Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients Journal of Gene Medicine 2005 7 5 552 564 (Pubitemid 40744521)
30. Podsakoff G. M., Engel B. C., Carbonaro D. A., Choi C., Smogorzewska E. M., Bauer G., Selander D., Csik S., Wilson K., Betts M. R., Koup R. A., Nabel G. J., Bishop K., King S., Schmidt M., von Kalle C., Church J. A., Kohn D. B., Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34+ cells Molecular Therapy 2005 12 1 77 86 (Pubitemid 40862359)
31. Symonds G. P., Johnstone H. A., Millington M. L., Boyd M. P., Burke B. P., Breton L. R., The use of cell-delivered gene therapy for the treatment of HIV/AIDS Immunologic Research 2010 48 1-3 84 98
32. Mitsuyasu R. T., Merigan T. C., Carr A., Zack J. A., Winters M. A., Workman C., Bloch M., Lalezari J., Becker S., Thornton L., Akil B., Khanlou H., Finlayson R., McFarlane R., Smith D. E., Garsia R., Ma D., Law M., Murray J. M., Von Kalle C., Ely J. A., Patino S. M., Knop A. E., Wong P., Todd A. V., Haughton M., Fuery C., Macpherson J. L., Symonds G. P., Evans L. A., Pond S. M., Cooper D. A., Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34 + cells Nature Medicine 2009 15 3 285 292
33. Bauer G., Selander D., Engel B., Carbonaro D., Csik S., Rawlings S., Church J., Kohn D. B., Gene therapy for pediatric AIDS Annals of the New York Academy of Sciences 2000 918 318 329
34. Michienzi A., Castanotto D., Lee N., Li S., Zaia J. A., Rossi J. J., RNA-mediated inhibition of HIV in a gene therapy setting Annals of the New York Academy of Sciences 2003 1002 63 71 (Pubitemid 38253330)
35. DiGiusto D. L., Krishnan A., Li L., Li H., Li S., Rao A., Mi S., Yam P., Stinson S., Kalos M., Alvarnas J., Lacey S. F., Yee J.-K., Li M., Couture L., Hsu D., Forman S. J., Rossi J. J., Zaia J. A., RNA-based gene therapy for HIV with lentiviral vector-modified CD34+ cells in patients undergoing transplantation for AIDS-related lymphoma Science Translational Medicine 2010 2 36 43
36. Sun L. Q., Ely J. A., Gerlach W., Symonds G., Anti-HIV Ribozymes Molecular Biotechnology 1997 7 3 241 251 (Pubitemid 127498404)
37. Sun L. Q., Wang L., Gerlach W. L., Symonds G., Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA Nucleic Acids Research 1995 23 15 2909 2913
38. Sun L. Q., Pyati J., Smythe J., Wang L., Macpherson J., Gerlach W., Symonds G., Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs Proceedings of the National Academy of Sciences of the United States of America 1995 92 16 7272 7276
39. Wang L. I., Witherington C., King A., Gerlach W. L., Carr A., Penny R., Cooper D., Symonds G., Sun L. Q., Preclinical characterization of an anti-tat ribozyme for therapeutic application Human Gene Therapy 1998 9 9 1283 1291 (Pubitemid 28312893)
40. Rossi J. J., Ribozyme therapy for HIV infection Advanced Drug Delivery Reviews 2000 44 1 71 78
41. Food Drug Administration, C.B.E.R. (U.S. Department of Health and Human Services, Rockville, Md, USA, 2006)
42. Murray J. M., Fanning G. C., Macpherson J. L., Evans L. A., Pond S. M., Symonds G. P., Mathematical modelling of the impact of haematopoietic stem cell-delivered gene therapy for HIV Journal of Gene Medicine 2009 11 12 1077 1086
43. Malech H. L., Maples P. B., Whiting-Theobald N., Linton G. F., Sekhsaria S., Vowells S. J., Li F., Miller J. A., Decarlo E., Holland S. M., Leitman S. F., Carter C. S., Butz R. E., Read E. J., Fleisher T. A., Schneiderman R. D., Van Epps D. E., Spratt S. K., Maack C. A., Rokovich J. A., Cohen L. K., Gallin J. I., Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease Proceedings of the National Academy of Sciences of the United States of America 1997 94 22 12133 12138 (Pubitemid 27467855)
44. Aiuti A., Slavin S., Aker M., Ficara F., Deola S., Mortellaro A., Morecki S., Andolfi G., Tabucchi A., Carlucci F., Marinello E., Cattaneo F., Vai S., Servida P., Miniero R., Roncarolo M. G., Bordignon C., Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning Science 2002 296 5577 2410 2413 (Pubitemid 34734219)
45. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M. P., Wulffraat N., Leboulch P., Lim A., Osborne C. S., Pawliuk R., Morillon E., Sorensen R., Forster A., Fraser P., Cohen J. I., De Saint Basile G., Alexander I., Wintergerst U., Frebourg T., Aurias A., Stoppa-Lyonnet D., Romana S., Radford-Weiss I., Gross F., Valensi F., Delabesse E., Macintyre E., Sigaux F., Soulier J., Leiva L. E., Wissler M., Prinz C., Rabbitts T. H., Le Deist F., Fischer A., Cavazzana-Calvo M., LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 Science 2003 302 5644 415 419 (Pubitemid 37296260)
46. Ott M. G., Schmidt M., Schwarzwaelder K., Stein S., Siler U., Koehl U., Glimm H., Khlcke K., Schilz A., Kunkel H., Naundorf S., Brinkmann A., Deichmann A., Fischer M., Ball C., Pilz I., Dunbar C., Du Y., Jenkins N. A., Copeland N. G., Lthi U., Hassan M., Thrasher A. J., Hoelzer D., Von Kalle C., Seger R., Grez M., Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 Nature Medicine 2006 12 4 401 409
47. Carter C. C., Onafuwa-Nuga A., McNamara L. A., Riddell J., Bixby D., Savona M. R., Collins K. L., HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs Nature Medicine 2010 16 4 446 451